Captrust Financial Advisors bought a new stake in Monsanto (NYSE:MON) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 49,642 shares of the basic materials company’s stock, valued at approximately $5,797,000.
Several other large investors have also recently added to or reduced their stakes in MON. Capital International Investors boosted its position in Monsanto by 10.3% during the third quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock worth $1,119,650,000 after purchasing an additional 872,377 shares during the period. York Capital Management Global Advisors LLC boosted its position in Monsanto by 14.8% during the fourth quarter. York Capital Management Global Advisors LLC now owns 6,059,514 shares of the basic materials company’s stock worth $707,630,000 after purchasing an additional 781,259 shares during the period. Geode Capital Management LLC boosted its position in Monsanto by 13.5% during the fourth quarter. Geode Capital Management LLC now owns 4,840,855 shares of the basic materials company’s stock worth $564,174,000 after purchasing an additional 575,084 shares during the period. Renaissance Technologies LLC boosted its position in Monsanto by 30.6% during the fourth quarter. Renaissance Technologies LLC now owns 2,881,300 shares of the basic materials company’s stock worth $336,478,000 after purchasing an additional 675,700 shares during the period. Finally, Janus Henderson Group PLC boosted its position in Monsanto by 57.1% during the third quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock worth $280,696,000 after purchasing an additional 851,369 shares during the period. 75.46% of the stock is owned by institutional investors and hedge funds.
In other news, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.79% of the stock is currently owned by company insiders.
Monsanto (NYSE:MON) last posted its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. During the same period in the prior year, the business posted $0.21 EPS. The firm’s quarterly revenue was up .3% compared to the same quarter last year. research analysts forecast that Monsanto will post 5.76 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be issued a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date of this dividend is Thursday, April 5th. Monsanto’s dividend payout ratio is currently 39.93%.
A number of research firms have commented on MON. Wells Fargo & Co reaffirmed a “market perform” rating and set a $128.00 price objective (up from $118.00) on shares of Monsanto in a research report on Wednesday, January 17th. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research report on Tuesday, January 16th. Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Finally, Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $127.30.
TRADEMARK VIOLATION WARNING: “49,642 Shares in Monsanto (MON) Acquired by Captrust Financial Advisors” was originally posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.themarketsdaily.com/2018/03/12/49642-shares-in-monsanto-mon-acquired-by-captrust-financial-advisors.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.